AstraZeneca has announced that the National Institute for Health and Care Excellence (NICE) has issued Technology Appraisal Guidance (TAG) for LYNPARZA® (olaparib), recommending it as a cost… …read more
AstraZeneca has announced that the National Institute for Health and Care Excellence (NICE) has issued Technology Appraisal Guidance (TAG) for LYNPARZA® (olaparib), recommending it as a cost… …read more
Comments are closed.
Nice posts! 🙂
___
Sanny
Look my site is good
___
http://afcmarseille.com